MLL Legal advised Artefact, a portfolio company of the private investment company Ardian, on the acquisition of Effixis, a consultancy AI company. On 31 July 2024, Artefact, a global company dedicated to accelerating the adoption of data
Tags :sx3
Homburger has acted as legal advisor to Central Group, a leading Thai retail and property conglomerate, in its acquisition of the operational business of Magazine zum Globus. The acquisition, which involves luxury department stores across
Niederer Kraft Frey (NKF) has acted as legal advisor to Axpo Holding AG in securing a JPY 42 billion (approximately CHF 250 million) Samurai loan. The financing is aimed at supporting Axpo’s current business operations and
Aude Peyrot (pictured) has joined the team of Walder Wyss as a new partner in their Geneva office. Aude Peyrot’s career path Dr. Aude Peyrot is a recognized specialist in inheritance law, coming from
Lalive partner Bernd Ehle (pictured) has been appointed to the Board of Directors of the Kigali International Arbitration Centre (KIAC) for a three-year term. KIAC KIAC, established in 2010 and officially launched in May 2012, is one
Dentons‘ Spanish partner Luis Belart (pictured) along with associates Mar Sánchez-Contador and Icíar Pérez-Puente are part of the pilot project being tested in continental Europe. Dentons continues to be at the forefront
Baker McKenzie advises Privatbank IHAG Zürich on the sale of its client book to Bank Vontobel, advised by Bär & Karrer, by way of an asset deal. Vontobel is set to acquire PB
Niederer Kraft Frey (“NKF”) advised Calibre Scientific on the acquisition of wikuma GmbH. NKF team The NKF team was led by corporate/M&A partner Patrik Peyer (pictured), working with associate Sabrina Gysi and
MLL Legal assisted GCLH and Meanquest on the purchase of a majority stake in the company MIB Suisse . GCLH and Meanquest will bring their know-how to MIB’s customers through its various business lines, including
Advestra advised eMolecules and Avista Healthcare Partners (of which eMolecules is a porfolio company), on the acquisition of all shares in Synple Chem. The acquisition strategically expands eMolecules’ product and service portfolio to
